Featured Research

from universities, journals, and other organizations

Drug Reduces Daily 'Off' Time For Parkinson Patients

Date:
April 3, 2007
Source:
American Academy of Neurology
Summary:
Parkinson disease patients taking the drug, ropinirole 24-hour prolonged release significantly reduced their daily "off" time in which Parkinson's symptoms like tremor, slowness, stiffness and walking difficulty return as drugs wear off, according to a recent study.

Parkinson disease patients taking the drug, ropinirole 24-hour prolonged release significantly reduced their daily "off" time in which Parkinson's symptoms like tremor, slowness, stiffness, and walking difficulty return as drugs wear off, according to a study published in the April 3, 2007, issue of Neurology®, the scientific journal of the American Academy of Neurology.

The study involved 393 people with Parkinson disease who weren't responding optimally to the widely used treatment for Parkinson, levodopa. For the study, half of the group took the prolonged release version of the drug ropinirole, called ropinirole 24-hour, and levodopa for six months. The other half took placebo and levodopa. Other Parkinson disease medications were not changed during the study.

Researchers found those people taking the drug reduced their average daily "off" time by 2.1 hours compared to .3 hours in the placebo group.

"Ropinirole 24-hour prolonged release, when taken with levodopa, is effective in reducing daily 'off' time for Parkinson patients who aren't getting the best results from levodopa," said study author Rajesh Pahwa, MD, with the University of Kansas Medical Center in Kansas City, Kansas, and Fellow of the American Academy of Neurology. "We also found the drug helped improve quality of life and motor function."

Among those taking ropinirole, researchers found significant improvements in troublesome Parkinson symptoms, quality of life, depression, emotional well-being, stigma, and sleep. Over half of the people in the ropinirole group were classified as much improved" or "very much improved" compared to 14 percent in the placebo group. Those taking ropinirole were also able to reduce their dosage of levodopa.

According to the study, common side effects were involuntary movements, nausea, dizziness, drowsiness, hallucinations, and sudden drops in blood pressure. The 24-hour prolonged release ropinirole appears to be as effective as immediate release ropinirole and better tolerated.

The study was supported by GlaxoSmithKline and Skye Pharma, makers of prolonged release ropinirole.


Story Source:

The above story is based on materials provided by American Academy of Neurology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Neurology. "Drug Reduces Daily 'Off' Time For Parkinson Patients." ScienceDaily. ScienceDaily, 3 April 2007. <www.sciencedaily.com/releases/2007/04/070402162129.htm>.
American Academy of Neurology. (2007, April 3). Drug Reduces Daily 'Off' Time For Parkinson Patients. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2007/04/070402162129.htm
American Academy of Neurology. "Drug Reduces Daily 'Off' Time For Parkinson Patients." ScienceDaily. www.sciencedaily.com/releases/2007/04/070402162129.htm (accessed August 20, 2014).

Share This




More Health & Medicine News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Freetown a City on Edge

Ebola-Hit Sierra Leone's Freetown a City on Edge

AFP (Aug. 19, 2014) — Residents of Sierra Leone's capital voice their fears as the Ebola virus sweeps through west Africa. Duration: 00:56 Video provided by AFP
Powered by NewsLook.com
101-Year-Old Working Man Has All The Advice You Need

101-Year-Old Working Man Has All The Advice You Need

Newsy (Aug. 19, 2014) — Herman Goldman has worked at the same lighting store for almost 75 years. Find out his secrets to a happy, productive life. Video provided by Newsy
Powered by NewsLook.com
Researcher Testing on-Field Concussion Scanners

Researcher Testing on-Field Concussion Scanners

AP (Aug. 19, 2014) — Four Texas high school football programs are trying out an experimental system designed to diagnose concussions on the field. The technology is in response to growing concern over head trauma in America's most watched sport. (Aug. 19) Video provided by AP
Powered by NewsLook.com
American Ebola Patient Apparently Improving, Outbreak Is Not

American Ebola Patient Apparently Improving, Outbreak Is Not

Newsy (Aug. 19, 2014) — Nancy Writebol, an American missionary who contracted Ebola, is apparently getting better, according to her husband. The outbreak, however, is not. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins